MetAlert, Inc. (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, has announced the launch of its next-generation 4G GPS SmartSole in Denmark and Norway through its long-term distribution partner Safecall Aps. This development represents a significant step in MetAlert’s expansion, making it a stock worth watching.
Safecall Aps, a market leader in providing GPS telehealth products to seniors in both the private and government healthcare sectors, has been supplying healthcare services for over 16 years. The partnership between MetAlert and Safecall is strategically important as Safecall supplies all the leading Alzheimer’s and dementia treatment centers and clinics in Denmark and Norway.
The Scandinavian countries are among the most advanced nations in the world in utilizing GPS tracking and remote patient monitoring technology for patients with mild cognitive impairment (MCI). With MetAlert’s manufacturing ramping back up, the company is in a strong position to fulfill backorders and get back to normal delivery cycles.
The Alzheimer’s Association has noted that approximately 12 to 18 percent of people aged 60 or older are currently living with MCI, which makes MetAlert’s technology crucial in promoting lifestyle wellness and independence for these patients. MetAlert’s GPS SmartSole is the world’s first invisible wearable technology tracking device designed for individuals at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury.
MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has a strong international presence with distributors servicing customers across the globe in over 40 countries. Additionally, MetAlert is a U.S. Military Government contractor, and its clientele includes public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers.
In summary, MetAlert’s launch of its 4G GPS SmartSole in Denmark and Norway signifies an important milestone for the company. With a robust distribution partnership, a growing global presence, and a strong focus on technology innovation, MetAlert is a stock to watch for investors interested in companies with strong fundamentals in the healthcare sector.
